Literature DB >> 30928631

RETRACTED: Ginsenoside Rg3 inhibits growth and epithelial-mesenchymal transition of human oral squamous carcinoma cells by down-regulating miR-221.

Zhou Cheng1, Dayuan Xing2.   

Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the Editor-in-Chief. Given the comments regarding this article https://pubpeer.com/publications/917A4D8593F06C8E5ADC7AA0A30136, particularly regarding the background of the Western Blots from Figure 2B, the journal requested the authors to provide the raw data. However, the authors were not able to fulfil this request and therefore the Editor-in-Chief decided to retract the article.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Anti-cancer; Ginsenoside Rg3; MicroR-221; Oral squamous cell carcinoma; TIMP3

Mesh:

Substances:

Year:  2019        PMID: 30928631     DOI: 10.1016/j.ejphar.2019.03.040

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   5.195


  11 in total

1.  Xinmai 'an extract enhances the efficacy of sildenafil in the treatment of pulmonary arterial hypertension via inhibiting MAPK signalling pathway.

Authors:  Yaolu Zhu; Yabin Sun; Shichang Zhang; Chuyuan Li; Yiwei Zhao; Boxin Zhao; Guofeng Li
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

Review 2.  Reversal of Epithelial-Mesenchymal Transition by Natural Anti-Inflammatory and Pro-Resolving Lipids.

Authors:  Chang Hoon Lee
Journal:  Cancers (Basel)       Date:  2019-11-21       Impact factor: 6.639

3.  Ginsenoside Rg3 Prevents Oncogenic Long Noncoding RNA ATXN8OS from Inhibiting Tumor-Suppressive microRNA-424-5p in Breast Cancer Cells.

Authors:  Heejoo Kim; Hwee Won Ji; Hyeon Woo Kim; Sung Hwan Yun; Jae Eun Park; Sun Jung Kim
Journal:  Biomolecules       Date:  2021-01-18

4.  Bioinformatics analysis of the expression and role of microRNA-221-3p in head and neck squamous cell carcinoma.

Authors:  Ziyan Zhou; Wenling Wu; Jixi Li; Chang Liu; Zixi Xiao; Qinqiao Lai; Rongxing Qin; Mingjun Shen; Shuo Shi; Min Kang
Journal:  BMC Cancer       Date:  2021-04-12       Impact factor: 4.638

5.  Inhibitory role of ginsenoside Rb2 in endothelial senescence and inflammation mediated by microRNA‑216a.

Authors:  Yutong Chen; Shuting Wang; Shujun Yang; Rongxia Li; Yunyun Yang; Yu Chen; Weili Zhang
Journal:  Mol Med Rep       Date:  2021-03-31       Impact factor: 2.952

6.  MicroRNA-21 Contributes to Cutaneous Squamous Cell Carcinoma Progression via Mediating TIMP3/PI3K/AKT Signaling Axis.

Authors:  Shuhong Yin; Xiuying Lin
Journal:  Int J Gen Med       Date:  2021-01-08

Review 7.  miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review.

Authors:  Maria Teresa Di Martino; Mariamena Arbitrio; Daniele Caracciolo; Alessia Cordua; Onofrio Cuomo; Katia Grillone; Caterina Riillo; Giulio Caridà; Francesca Scionti; Caterina Labanca; Caterina Romeo; Maria Anna Siciliano; Maria D'Apolito; Cristina Napoli; Martina Montesano; Valentina Farenza; Valentina Uppolo; Michele Tafuni; Federica Falcone; Giuseppe D'Aquino; Natale Daniele Calandruccio; Francesco Luciano; Licia Pensabene; Pierosandro Tagliaferri; Pierfrancesco Tassone
Journal:  Mol Ther Nucleic Acids       Date:  2022-02-11       Impact factor: 8.886

8.  Analysis on Value of Applying Serum miR-144 and miR-221 Levels in Diagnosing Atherosclerosis.

Authors:  Jianxiu Zhang; Qian Cao; Zhenying Zhang; Chenguang Du; Lizhong Wang
Journal:  J Healthc Eng       Date:  2022-01-25       Impact factor: 2.682

Review 9.  Targeting Epigenetic Regulatory Enzymes for Cancer Therapeutics: Novel Small-Molecule Epidrug Development.

Authors:  Ye Jin; Tianjia Liu; Haoming Luo; Yangyang Liu; Da Liu
Journal:  Front Oncol       Date:  2022-03-28       Impact factor: 6.244

Review 10.  Two Worlds Colliding: The Interplay Between Natural Compounds and Non-Coding Transcripts in Cancer Therapy.

Authors:  Alexandru A Sabo; Maria Dudau; George L Constantin; Tudor C Pop; Christoph-M Geilfus; Alessio Naccarati; Mihnea P Dragomir
Journal:  Front Pharmacol       Date:  2021-07-06       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.